Search jobs
Queen Square Analytics launches to develop breakthrough imaging analysis technology for neurological clinical trials
LONDON, UK – 24 May 2021 – Queen Square Analytics, a new UCL spinout, has formally launched to apply next-generation image analysis technology to neurological clinical trials. Born out of work conducted in the university's multiple sclerosis clinical trials research office at the Queen Square Institute of Neurology and the Centre for Medical Image Computing, Queen Square Analytics will harness technology to measure the effectiveness of treatments in areas such as multiple sclerosis.
This is another marker of UCL's highly successful approach to technology transfer, taking artificial intelligence and image processing from academic research labs to direct patient benefit. Taking that technology and making it industry ready for medical imaging has taken years of pioneering data analysis and using machine learning at three UCL Departments of Queen Square Institute of Neurology, Computer Science and Medical Physics and Biomedical Engineering to ensure the technology leads in the analysis of clinical trial data, rather than historically being led by human raters.